drugs
Analysis: Life Saving Innovation at Alarming Prices
We do scientific innovation very well. New therapies — from anesthesia in 1850, antibiotics in 1928, organ transplants in 1960, to COVID vaccines now — are improving our lives and extending life expectancy. However, healthcare costs now consume 20% of our economy, and we aren’t getting our money’s worth. Complicating the issue, Pharma’s extreme drug…
Read MoreBarriers to Fair Access Report prompts insurers to improve access to 11 drugs
There’s a lot of very appropriate focus on the unfairness of unwarranted drug prices. But an equally important key to patients accessing those drugs is the fairness of insurance policies. To keep premiums affordable, insurers must balance, even encourage, appropriate to access care, while deterring overtreatment and excessive prices. ICER, the nation’s leading value assessment…
Read MoreCTNJ op-ed: Health insurance affordability review is good, but it’s no silver bullet
A movement to include affordability in the Insurance Department’s review of health insurance premiums is gaining champions. That’s a good thing. The best care is useless if you can’t afford it. Holding insurers accountable for lowering costs is important, but it’s not going to solve everything. We need to do much more to get costs…
Read MoreNo evidence to justify increases for 7 of top 10 most costly drugs
The latest Unsupported Price Increase report from the Institute for Clinical and Economic Review finds that, last year, seven of the ten most costly drugs in the US that raised net prices well over the rate of general inflation, had no new clinical evidence of effectiveness to justify the increases. The increases on just these…
Read MoreMental health workforce swamped by need, what needs to happen
A few recent reports have raised alarms about whether our healthy system’s mental health capacity can meet the need, and what we can do about it. The need is great. A mid-September Household Pulse Census survey found that 361,729 Connecticut residents reported feeling anxiety nearly every day and 219,164 reported depressive thoughts nearly every day.…
Read MoreStudy finds Americans living in liberal states, like CT, live longer but we can do better
Recently, working-age Americans’ mortality has reversed its historic declines, largely due to lack of progress on heart disease, and rising deaths due to alcohol, suicide, and drug poisoning. A new study finds that from 1999 to 2019, mortality for adults ages 25-64 was lower in states with liberal policies, like Connecticut, and worse in conservative…
Read MoreAnalysis: New study finds 1 in 5 households has medical debt that averages $21,687
Having health insurance is no longer the protection it used to be. A pair of new studies shine a bright light on inadequate insurance and its consequences – medical debt. Read more
Read MoreOp-Ed: Governor’s Healthcare Record Misses Opportunities
Last week, the Governor and his administration held a press conference nominally to promote their efforts to lower healthcare costs, but mostly for damage control. There’s been understandable criticism of the state insurance department’s decision to trim the unjustified insurer rate increase requests for next year from 20% to 13%. Insurers have been very profitable…
Read MoreOP-ED: Be careful in making changes when the glass is half full
There is good news on Connecticut health spending – and we can use it. Analysis of new data has found, not surprisingly, that Connecticut residents spend a lot on healthcare. But the good news is that our average annual rate of growth, at 1.8%, was the ninth lowest among states from 2013 to 2019. We…
Read MoreGood news on CT healthcare costs
New data from researchers at the University of Washington on state per person healthcare spending finds that between 2013 and 2019, Connecticut’s costs grew at the ninth lowest level among states. We dropped from seventh highest in the US in 2014 to eleventh in 2019. Our growth rate was lower than nearby comparator states and…
Read More